For Healthcare Professionals:
Ichthyosis — A Quick Reference Guide
A printable summary for GPs, A&E doctors, and non-specialist clinicians encountering ichthyosis patients.
What is Ichthyosis?
Ichthyosis is a group of genetic skin disorders characterised by abnormal skin barrier function and excessive scaling. The term derives from the Greek word for "fish" due to the scale-like appearance. Most forms are inherited; a few are acquired.
Key pathophysiology: Mutations in genes encoding structural proteins (keratins, filaggrin), lipid metabolism enzymes, or desquamation regulators → impaired epidermal barrier → excessive transepidermal water loss, abnormal keratinocyte differentiation, and hyperkeratosis.
Prevalence: Ichthyosis Vulgaris (~1 in 250) is common. Rarer forms (X-linked, lamellar, harlequin, Netherton) range from 1:100,000 to 1:300,000.
The Main Types at a Glance
| Type | Gene(s) | Key Clinical Features | Severity |
|---|---|---|---|
| Ichthyosis Vulgaris | FLG (filaggrin) | Fine white scales on extensor surfaces, spares flexures. Keratosis pilaris. Often co-exists with atopic disease. | Mild |
| X-Linked Ichthyosis | STS (steroid sulfatase) | Brown/grey scales on trunk and limbs, spares palms/soles. Males only (X-linked recessive). Corneal opacities (asymptomatic). | Mild-Moderate |
| Lamellar Ichthyosis | TGM1, ABCA12, others | Large plate-like brown/grey scales over whole body. Collodion baby at birth. Ectropion (eyelid eversion). Severe heat intolerance (anhidrosis). | Severe |
| Harlequin Ichthyosis | ABCA12 | Thick armour-like plates at birth. Ectropion, eclabium (lip eversion). Requires NICU care. High neonatal mortality without intensive management. | Critical |
| Epidermolytic Ichthyosis (EI/EHK) | KRT1, KRT10 | Neonatal blistering → thick corrugated scales. Odour due to bacterial colonisation. Palmoplantar keratoderma (esp. KRT1). | Moderate-Severe |
| Netherton Syndrome | SPINK5 | Ichthyosis + "bamboo hair" (trichorrhexis invaginata) + severe atopic disease (food allergies, asthma, eczema). Failure to thrive in infancy. | Severe (systemic) |
| KID Syndrome | GJB2 | Keratitis (progressive corneal vascularisation → blindness), Ichthyosis (transgressive pattern), Deafness (sensorineural). Increased SCC risk. | Severe (multi-system) |
Clinical Pearl: Collodion Baby ≠ Poor Prognosis
Not all collodion babies develop severe ichthyosis. A collodion membrane at birth is a phenotype, not a diagnosis. Outcomes range from:
- Self-Healing Collodion Baby → virtually normal skin by adolescence (best prognosis)
- Lamellar Ichthyosis → lifelong severe scaling (moderate-severe prognosis)
- Harlequin Ichthyosis → critical neonatal management required (life-threatening if untreated)
Action: All collodion babies require urgent neonatal dermatology review for accurate classification and management.
Common Presentations GPs Miss
1. "It's just dry skin"
Mild ichthyosis (especially vulgaris or X-linked) is often dismissed as cosmetic "dry skin" for years. Key differentiator: ichthyosis doesn't respond to standard moisturisers alone and has characteristic distribution patterns (e.g., spares flexures in vulgaris, affects trunk in X-linked).
2. Misdiagnosed as eczema
Ichthyosis and atopic eczema frequently coexist (especially in FLG-related vulgaris). However, ichthyosis is not itchy unless superimposed eczema is present. If "eczema" only partially responds to topical steroids and has scaling rather than weeping, consider ichthyosis.
3. "Cradle cap" that never resolves
Persistent scaling in infancy, especially if generalised or involving trunk/limbs, warrants consideration of congenital ichthyosis. True cradle cap (seborrhoeic dermatitis) resolves by 6–12 months.
4. Unrecognised systemic forms
Netherton Syndrome (ichthyosis + severe allergies + "bamboo hair") and KID Syndrome (ichthyosis + keratitis + deafness) are frequently diagnosed late. Ask about hair abnormalities, hearing, vision, atopic symptoms in any child with significant scaling.
What NOT to Do
- Prolonged topical corticosteroids: Ichthyosis is not inflammatory. Steroids thin already-fragile skin and don't address the underlying barrier defect. Use only for superimposed eczema.
- Prescribing standard moisturisers and discharging: Ichthyosis requires emollients in large quantities (500g–1kg weekly for severe forms) plus keratolytics (urea, salicylic acid). "Try E45" is inadequate.
- Ignoring neonatal presentations: Any neonate with widespread scaling, collodion membrane, or blistering needs urgent dermatology input. Delayed recognition of Harlequin can be fatal.
- Not recognising retinoid indications: Moderate-severe forms (lamellar, EI, CIE) often require systemic retinoids (acitretin). Refer to dermatology; do not try to manage in primary care alone.
Urgent Referral Criteria
- Collodion baby / neonatal presentation: Any neonate with membrane, widespread blistering, or thick scaling → urgent neonatal dermatology review
- Suspected Harlequin Ichthyosis: Thick armour-like plates at birth, severe ectropion/eclabium → immediate NICU transfer
- Failure to thrive: Poor weight gain + ichthyosis (especially if atopic features) → consider Netherton Syndrome
- Suspected systemic complications: Ichthyosis + neurological symptoms (think Refsum disease), corneal involvement (KID syndrome), or severe infection
- Moderate-severe scaling not responding to emollients + keratolytics
- Suspected genetic ichthyosis requiring diagnosis (genetic testing, skin biopsy)
- Child with scaling + other features (hair abnormality, atopy, deafness, visual symptoms)
- Adult with new-onset acquired ichthyosis (exclude malignancy, autoimmune disease)
Useful Referral Pathways
Dermatology
Primary specialist. All ichthyosis patients need dermatology input for diagnosis, genetic testing, and systemic treatment (retinoids).
Referral: "?Ichthyosis — characteristic scaling, family history, request genetic testing and management plan"
Clinical Genetics
Genetic counselling for inheritance patterns, prenatal diagnosis options, and family screening. Especially important for autosomal dominant forms (EI) and autosomal recessive forms (lamellar, Harlequin).
Ophthalmology
Essential for: KID Syndrome (progressive keratitis → blindness), lamellar/Harlequin (ectropion management), X-linked (corneal opacities — usually asymptomatic but needs monitoring).
Audiology
Hearing assessment for KID Syndrome (sensorineural deafness) and Netherton Syndrome (occasional hearing involvement). Also for lamellar (ear canal obstruction by scale).
Allergy/Immunology
Urgent for Netherton Syndrome — severe food allergies with anaphylaxis risk. Also useful for vulgaris with significant atopic co-morbidity.
Paediatrics (General)
Coordinate multi-specialty care for complex cases. Monitor growth (failure to thrive in Netherton), developmental milestones, and psychosocial impact.
Key Resources for Patients & Professionals
FIRST (US)
Foundation for Ichthyosis & Related Skin Types — leading US patient organisation.
ISG UK (UK)
Ichthyosis Support Group — UK patient charity with helpline, specialist finder, and family support.
ichthyosis.org.uk | Helpline: 0800 368 9621
ICER (Europe)
European Network for Ichthyosis — research network and clinical trial coordination.
Orphanet
Comprehensive rare disease database with GP-friendly summaries of all ichthyosis types.
Prescribing Tip: Emollients in Ichthyosis
Quantity matters. Standard 100g tubes are inadequate. For moderate-severe ichthyosis:
- Adults: 500g–1kg emollient weekly (prescribe 4× 500g tubs monthly)
- Children: 250–500g weekly depending on age and severity
- Keratolytics: Urea 10–40% or salicylic acid 2–6% are essential for scale reduction
- Bath additives: Emulsifying ointment, Balneum Plus, Oilatum (50–100ml per bath)
Fire safety warning: All paraffin-based emollients are flammable. Warn patients about smoking and open flames. Bedding/clothing should be washed at high temperature regularly.
When to Consider Systemic Treatment
Systemic retinoids (acitretin, isotretinoin) are highly effective for moderate-severe ichthyosis but require specialist initiation and monitoring:
Indications for Retinoid Therapy
- Lamellar ichthyosis, CIE, or Harlequin (after infancy) — first-line systemic treatment
- Epidermolytic ichthyosis with severe scaling, blistering, or odour
- Failure of intensive topical therapy (emollients + keratolytics) to control symptoms
- Significant functional impairment or psychosocial impact
Important: GPs should not initiate retinoids for ichthyosis. Refer to dermatology. Requires baseline bloods (LFTs, lipids, pregnancy test), contraception counselling (teratogenic), and 3-monthly monitoring.
Questions? Need specialist advice?
For complex cases or urgent queries, contact your regional dermatology department. Most tertiary centres have specialist ichthyosis clinics or access to national experts.
Patient resources: Direct patients to ichthyosis.org.uk (UK), firstskinfoundation.org (US), or this website for detailed management guides.